.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,286,763

« Back to Dashboard

Details for Patent: 5,286,763

Title: Bioerodible polymers for drug delivery in bone
Abstract:Bioerodible polymers which degrade completely into nontoxic residues over a clinically useful period of time, including polyanhydrides, polyorthoesters, polyglycolic acid, polylactic acid, and copolymers thereof, are used for the delivery of bioactive agents, including antibiotics, chemotherapeutic agents, inhibitors of angiogenesis, and simulators of bone growth, directly into bone.
Inventor(s): Gerhart; Tobin N. (Brockline, MA), Laurencin; Cato T. (Somerville, MA), Domb; Abraham J. (Baltimore, MD), Langer; Robert S. (Newton, MA), Hayes; Wilson C. (Lincoln, MA)
Assignee: Massachusetts Institute of Technology (Cambridge, MA)
Filing Date:Jun 30, 1992
Application Number:07/908,438
Claims:1. A method for delivering a bioactive molecule to bone comprising

making a polymeric composition including as structural and functional components a polyanhydride, and

bioactive molecules, and

2. The method of claim 1 wherein the bioactive molecules are selected from the group consisting of antibiotics, chemotherapeutic agents, bone morphogenic factors, angiogenesis inhibitors, and bone growth factors.

3. The method of claim 1 wherein the polyanhydride is selected to degrade over a period of less than approximately a year.

4. The method of claim 1 further comprising mixing bioactive molecules with the polyanhydride and implanting the material in bone.

5. The method of claim 1 further comprising mixing filler materials with polyanhydride to increase the structural strength of the polyanhydride.

6. The method of claim 1 for treatment of tumors comprising removing tumor material and implanting the polyanhydride-bioactive molecules in place thereof.

7. The method of claim 1 further comprising mixing the polyanhydride and bioactive material with structural and adhesive materials to form a bond cement.

8. A method for delivering a bioactive molecule to bone comprising making a polyanhydride composition including as structural and functional components:

a polyanhydride and bioactive molecules,

in a bone cement.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc